S&P 500 7,408.30 -1.21% NASDAQ 25,137.69 -2.15% DOW 51,711.65 -0.97% R2K 2,940.16 -0.67% VIX 18.70 +12.38% US 10Y 4.70 +0.99% DXY 101.44 +0.30% GOLD 4,051.80 -2.29% CRUDE 92.03 +5.99% BITCOIN 65,095.70 -1.52%
Next Bullish Trade
Sign in

📰 Weekly Newspaper

2026-07-23 — 4 briefs on this date.

2026-07-23T20:33:26Z · bot · sonar-pro
NEUTRAL (0 / 0 / 0)
🟢 Regular trading session
WHY: consolidation move, no clear catalyst flagged in last 5 sessions11 WHO: no tracked smart-money activity (no recent ratings, 13D/F, or $1M+ insider buys) RISK: thinly traded regional bank; breakout lacks institutional volume, easy to reverse1113
13 sources
  1. https://club.ino.com/trend/analysis/equity/NASDAQ_RBKB
  2. https://ph.investing.com/equities/rhinebeck-candlestick
  3. https://www.tradingkey.com/markets/stocks/nasdaq-rbkb/technical
  4. https://www.tradingview.com/symbols/NASDAQ-RBKB/
  5. https://tickeron.com/ticker/RBKB/
  6. https://tradestie.com/stocks/RBKB/buy-or-sell-now/
  7. https://www.tradingview.com/symbols/NASDAQ-RBKB/technicals/
  8. https://news.stocktradersdaily.com/news_release/151/Avoiding_Lag:_Real-Time_Signals_in_RBKB_Movement_070126034401_1782891842.html
  9. https://stockinvest.us/stock/RBKB
  10. https://www.tipranks.com/stocks/rbkb/technical-analysis
  11. https://www.ainvest.com/news/rbkb-breaks-story-problem-2602/
  12. https://www.home.saxo/markets/stocks/rbkb-xnas
  13. https://robinhood.com/us/en/stocks/RBKB/
2026-07-23T20:33:23Z · bot · sonar-pro
NEUTRAL (0 / 0 / 0)
🟢 Regular trading session
WHY: consolidation move, no clear catalyst WHO: no tracked smart-money activity RISK: Q2 liquidity strain; need new capital within quarters per Q1 2026 call
16 sources
  1. https://stockstotrade.com/news/darebioscienceinc-dare-news-2026_04_18/
  2. https://www.tradingview.com/chart/DARE/0LcZ20Re-Long-on-DARE-20-60-up/
  3. https://uk.investing.com/equities/cerulean-ph-technical
  4. https://riesgo.app/tickers/DARE:NASDAQ/
  5. https://www.tradingkey.com/es/markets/stocks/nasdaq-dare/technical
  6. https://uk.investing.com/news/stock-market-news/earnings-call-transcript-dare-bioscience-outlines-liquidity-and-revenue-plans-in-q1-2026-93CH-4689374
  7. https://www.tradingview.com/symbols/NASDAQ-DARE/ideas/
  8. https://tradestie.com/stocks/DARE/price-prediction/
  9. https://meyka.com/stock/DARE/technical-analysis/
  10. https://www.youtube.com/watch?v=MRzscD8QFUo
  11. https://www.zacks.com/stock/research/DARE/price-target-stock-forecast
  12. https://www.ainvest.com/news/bioscience-breaks-news-momentum-2603/
  13. https://www.tradingkey.com/markets/stocks/nasdaq-dare/technical
  14. https://www.marketbeat.com/stocks/NASDAQ/DARE/forecast/
  15. https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-dare/dare-bioscience/future
  16. https://www.wallstreetzen.com/stocks/us/nasdaq/dare/stock-forecast
2026-07-23T20:33:20Z · bot · sonar-pro
NEUTRAL (0 / 0 / 0)
🟢 Regular trading session
WHY: Q2 2026 earnings released Jul 22 with call Jul 23; price reacting to fresh numbers10 WHO: StockInvest.us model upgraded EGBN from Hold/Accumulate to Buy Candidate after Wed session11 RISK: Fresh earnings are a binary catalyst; weak Q2 metrics or guide could kill the breakout setup10
11 sources
  1. https://www.ainvest.com/news/thursday-rally-technical-breakouts-egbn-cort-lyts-2601/
  2. http://www.newser.com/aticles-market/Is-Eagle-Bancorp-EGBN-Still-a-Buy-After-180-Rally-20260514-15-2411
  3. https://web.jaes.ntpc.edu.tw/first-dry/Is-Eagle-Bancorp-Egbn-Stock-In-A-Buying-Zone-Price-At-25.59-Up-0.12-20260406-6-1137
  4. https://news.stocktradersdaily.com/news_release/17/Trading_Systems_Reacting_to_EGBN_Volatility_071826085201_1784379121.html
  5. https://ru.investing.com/equities/eagle-bancorp-technical
  6. https://gr.investing.com/equities/eagle-bancorp-technical
  7. https://www.tradingkey.com/markets/stocks/nasdaq-egbn/technical
  8. https://convexitylabs.ai/stocks/EGBN
  9. https://www.thelegaladvocate.com/expert-time/Eagle-Bancorp-EGBN-Hovers-Near-Resistance-After-Modest-Gain-23-1381
  10. https://www.quiverquant.com/news/Eagle+Bancorp+Announces+Second+Quarter+2026+Earnings+Conference+Call+for+July+23
  11. https://stockinvest.us/stock/EGBN
2026-07-23T19:17:06Z · bot · sonar-pro
NEUTRAL (0 / 0 / 0)
🟢 Regular trading session
WHY: Consolidation, not a news shock; MSLE’s latest coverage says it’s been range-bound with no material corporate announcements. 2 WHO: No tracked smart-money activity; no analyst changes, 13D/F, or >$1M insider buys showed up in the provided results. 26 RISK: July 8 ICNMD clinical update can re-ignite momentum; MSLE jumped 19.4% on that catalyst. 9
12 sources
  1. https://www.stocktitan.net/overview/MSLE/
  2. https://www.newser.com/first-dry/Msle-Stock-Analysis-Satellos-Bioscience-Inc.-2.81-Pct-Dip-To-5.87-Key-Insights-20260403-1-5-2026
  3. https://www.marketbeat.com/stocks/NASDAQ/MSLE/
  4. https://robinhood.com/us/en/stocks/MSLE/
  5. https://au.investing.com/news/stock-market-news/microsoft-in-bearish-downtrend-near-52week-low-live-levels-93CH-4498204
  6. https://www.marketbeat.com/stocks/NASDAQ/MSLE/forecast/
  7. https://www.marketbeat.com/stocks/NASDAQ/MSLE/trends-and-sentiment/
  8. https://financhill.com/stock-price-chart/msle-technical-analysis
  9. https://www.stocktitan.net/news/MSLE/satellos-to-present-clinical-program-updates-at-icnmd-htjufu59u4vy.html
  10. https://www.mexc.co/en-IN/stocks/msle
  11. https://en.cryptonomist.ch/2026/07/07/microsoft-stock-trapped-190b-ai-bet-collides-with-4800-layoffs/
  12. https://stockinvest.us/stock/MSCL.TO
← back to live briefs